As a licensed Physician Assistant in Virginia with an independent DEA registration, the removal of the requirement for including the supervising physician's or podiatrist's name on prescriptions for Schedule II-V controlled substances is a necessary and logical step. This adjustment reflects the professional accountability of PAs, as listing a physician's name does improve patient care but instead creates unnecessary administrative burdens.